DL-AP5 Sodium saltCAS# 1303993-72-7 |
2D Structure
- Calyculin A
Catalog No.:BCC2457
CAS No.:101932-71-2
- Fumonisin B1
Catalog No.:BCC2461
CAS No.:116355-83-0
- Calcineurin Autoinhibitory Peptide
Catalog No.:BCC2456
CAS No.:148067-21-4
- Ceramide
Catalog No.:BCC2458
CAS No.:3102-57-6
- Fostriecin sodium salt
Catalog No.:BCC2460
CAS No.:87860-39-7
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 1303993-72-7 | SDF | Download SDF |
PubChem ID | 52974251 | Appearance | Powder |
Formula | C5H11NNaO5P | M.Wt | 219.11 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 100 mM in water | ||
Chemical Name | sodium;(4-amino-4-carboxybutyl)-hydroxyphosphinate | ||
SMILES | C(CC(C(=O)O)N)CP(=O)(O)[O-].[Na+] | ||
Standard InChIKey | KWRCYAPNGUCHOE-UHFFFAOYSA-M | ||
Standard InChI | InChI=1S/C5H12NO5P.Na/c6-4(5(7)8)2-1-3-12(9,10)11;/h4H,1-3,6H2,(H,7,8)(H2,9,10,11);/q;+1/p-1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Sodium salt of DL-AP5. Potent NMDA antagonist. |
DL-AP5 Sodium salt Dilution Calculator
DL-AP5 Sodium salt Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.5639 mL | 22.8196 mL | 45.6392 mL | 91.2784 mL | 114.0979 mL |
5 mM | 0.9128 mL | 4.5639 mL | 9.1278 mL | 18.2557 mL | 22.8196 mL |
10 mM | 0.4564 mL | 2.282 mL | 4.5639 mL | 9.1278 mL | 11.4098 mL |
50 mM | 0.0913 mL | 0.4564 mL | 0.9128 mL | 1.8256 mL | 2.282 mL |
100 mM | 0.0456 mL | 0.2282 mL | 0.4564 mL | 0.9128 mL | 1.141 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 2-Oxokolavenol
Catalog No.:BCN4716
CAS No.:130395-82-3
- Pungiolide A
Catalog No.:BCN8128
CAS No.:130395-54-9
- Decinnamoyltaxagifine
Catalog No.:BCN7329
CAS No.:130394-69-3
- Batimastat (BB-94)
Catalog No.:BCC1223
CAS No.:130370-60-4
- AC 45594
Catalog No.:BCC7544
CAS No.:13037-86-0
- MI-773 (SAR405838)
Catalog No.:BCC5648
CAS No.:1303607-60-4
- MI-773
Catalog No.:BCC5155
CAS No.:1303607-07-9
- Cathayanon I
Catalog No.:BCN3678
CAS No.:1303438-52-9
- Cathayanon H
Catalog No.:BCN3570
CAS No.:1303438-51-8
- CI 988
Catalog No.:BCC7430
CAS No.:130332-27-3
- H-D-Phe-OMe.HCl
Catalog No.:BCC3013
CAS No.:13033-84-6
- Fmoc-Oic-OH
Catalog No.:BCC3305
CAS No.:130309-37-4
- CHPG Sodium salt
Catalog No.:BCC7755
CAS No.:1303993-73-8
- (RS)-MCPG disodium salt
Catalog No.:BCC7756
CAS No.:1303994-09-3
- Paulownin
Catalog No.:BCN6160
CAS No.:13040-46-5
- (-)-Catechin gallate(CG)
Catalog No.:BCN5330
CAS No.:130405-40-2
- A-71623
Catalog No.:BCC7354
CAS No.:130408-77-4
- Peucedanocoumarin I
Catalog No.:BCN3434
CAS No.:130464-55-0
- Peucedanocoumarin II
Catalog No.:BCN3435
CAS No.:130464-56-1
- Peucedanocoumarin III
Catalog No.:BCN3471
CAS No.:130464-57-2
- Batimastat sodium salt
Catalog No.:BCC2075
CAS No.:130464-84-5
- A 68930 hydrochloride
Catalog No.:BCC7104
CAS No.:130465-39-3
- ent-11alpha-Hydroxyabieta-8(14),13(15)-dien-16,12alpha-olide
Catalog No.:BCN7330
CAS No.:130466-20-5
- L-655,708
Catalog No.:BCC7023
CAS No.:130477-52-0
Actions of D and L forms of 2-amino-5-phosphonovalerate and 2-amino-4-phosphonobutyrate in the cat spinal cord.[Pubmed:6145492]
Brain Res. 1982 Mar 11;235(2):378-86.
The separate optical enantiomers of 2-amino-5-phosphonovalerate (APV) and 2-amino-4-phosphonobutyrate (APB) have been tested for their ability to modify amino acid-induced and synaptic excitation of cat spinal neurones. D-(-)-APV was a highly potent and selective antagonist of amino acid-induced and synaptic excitation. Polysynaptic excitation was more susceptible to antagonism by D-APV than was monosynaptic excitation. It was considered likely that the depression of synaptic excitation by D-APV was due to the blockade of an excitatory amino acid transmitter acting at N-methyl-D-aspartate (NMDA) receptors. L-(+)-APV showed a relatively weak amino acid and synaptic blocking activity, which was similar in character to that of D-APV, and which may have been due to a slight residuum of the D isomer in the sample of the L form used. D-(-)-APB was a weak and relatively non-selective antagonist of amino acid-induced responses. In contrast, L-(+)-APB either had no effect or, at higher concentrations, enhanced these responses. Both isomers depressed synaptic responses in a proportion of the cells tested, the L form being the more potent isomer in producing this effect. Monosynaptic and polysynaptic excitations were both susceptible to this type of action. The depression of synaptic excitation by D-APB may have been due in some cases to the blockade of an excitatory amino acid transmitter. However, it is unlikely that the synaptic depressant action of L-APB is due to this mechanism.
The effects of a series of omega-phosphonic alpha-carboxylic amino acids on electrically evoked and excitant amino acid-induced responses in isolated spinal cord preparations.[Pubmed:7042024]
Br J Pharmacol. 1982 Jan;75(1):65-75.
1 The depressant actions on evoked electrical activity and the excitant amino acid antagonist properties of a range of omega-phosphonic alpha-carboxylic amino acids have been investigated in the isolated spinal cord preparations of the frog or immature rat. 2 When tested on dorsal root-evoked ventral root potentials, members of the homologous series from 2- amino-5-phosphonovaleric acid to 2-amino-8-phosphonooctanoic acid showed depressant actions which correlated with the ability of the substances to antagonize selectivity motoneuronal depolarizations induced by N-methyl-D-aspartate. 3 2-Amino-5-phosphonovalerate was the most potent substance of the series giving an apparent KD of 1.4 microM for the antagonism of responses to N-methyl-D-aspartate. 4 A comparison of the (+)- and (-)-forms of 2-amino-5-phosphonovalerate indicated that the N-methyl-D-aspartate antagonist activity and the neuronal depressant action of this substance were both due mainly to the (-)-isomer. 5 The (-)- and (+)-forms of 2-amino-4-phosphonobutyrate had different actions. The (-)-forms of this substance had a relatively weak and non-selective antagonist action on depolarizations induced by N-methyl-D-aspartate, quisqualate and kainate and a similarly weak depressant effect when tested on evoked electrical activity. The (+)-form was more potent than he (-)-form in depressing electrically evoked activity but did not antagonize responses to amino acid excitants. At concentrations higher than those required to depress electrically evoked activity, the (+)-form produced depolarization. This action was blocked by 2-amino-5-phosphonovalerate.